{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:40:07Z","timestamp":1789926007786,"version":"4.0.1"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The development of purple urine after methylene blue (methylthioninium chloride) and hydroxocobalamin co-administration is a rare clinical entity that has not been fully elucidated. A 47-year-old male presented to the emergency department with hypotension, cyanosis, and depressed mental status. The patient was noted to have profound peripheral and central cyanosis, as well as chocolate-colored arterial blood. He was treated with both methylene blue and hydroxocobalamin and developed purple urine for approximately 1\u00a0week.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Color chromatography was performed by placing the patient\u2019s urine directly onto absorbent filter paper. Urine spectrophotometry was performed utilizing the NanoDrop One\/One C UV\u2013Vis Spectrophotometer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Color chromatography of the urine was demonstrated clear separation of distinct red and blue phases. Urine spectrophotometry demonstrated near perfect overlap between the methylene blue + hydroxocobalamin absorbance spectrum and the patient\u2019s purple urine absorbance spectrum.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Purple urine secondary to methylene blue and hydroxocobalamin co-administration is due to combined urinary excretion of methylene blue (blue) and hydroxocobalamin (red), and not a novel purple metabolite. We anticipate that this is going to be an increasingly common clinical entity as the roles of both hydroxocobalamin and methylene blue expand from toxicologic antidotes to adjunct therapies for vasoplegia, poor cardiac output, and sepsis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s40620-023-01769-8","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T16:29:55Z","timestamp":1693326595000},"page":"491-494","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Spectrophotometric analysis of purple urine secondary to methylene blue and hydroxocobalamin co-administration"],"prefix":"10.1093","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8802-0920","authenticated-orcid":false,"given":"Jeremy","family":"Hardin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Galust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard Franklin","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binh","family":"Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond Theodore","family":"Suhandynata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,8,29]]},"reference":[{"key":"1769_CR1","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.ejcts.2005.07.011","volume":"28","author":"G Shanmugam","year":"2005","unstructured":"Shanmugam G (2005) Vasoplegic syndrome\u2014the role of methylene blue. Eur J Cardiothorac Surg 28:705\u2013710","journal-title":"Eur J Cardiothorac Surg"},{"issue":"6","key":"1769_CR2","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/00008571-199312000-00004","volume":"3","author":"A Watts","year":"1993","unstructured":"Watts A et al (1993) Beeturia and the biological fate of beetroot pigments. Pharmacogenetics 3(6):302\u2013311","journal-title":"Pharmacogenetics"},{"issue":"11","key":"1769_CR3","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.3346\/jkms.2014.29.11.1441","volume":"29","author":"H Gil","year":"2014","unstructured":"Gil H et al (2014) Diagnostic and therapeutic approach for acute paraquat intoxication. J Korean Med Sci 29(11):1441\u20131449","journal-title":"J Korean Med Sci"},{"issue":"8062","key":"1769_CR4","first-page":"502","volume":"1","author":"GB Barlow","year":"1978","unstructured":"Barlow GB (1978) Purple urine bags. Lancet 1(8062):502","journal-title":"Lancet"},{"issue":"3","key":"1769_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000499281","volume":"13","author":"N Sabanis","year":"2019","unstructured":"Sabanis N et al (2019) Purple urine bag syndrome: more than eyes can see. Curr Urol 13(3):125\u2013132","journal-title":"Curr Urol"},{"key":"1769_CR6","unstructured":"CYANOKIT [package insert] (2021) BTG International Inc., London, England. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/022041s019,%20020lbl.pdf"},{"key":"1769_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/15563650600811755","volume":"44","author":"W Uhl","year":"2006","unstructured":"Uhl W et al (2006) Safety of hydroxocobalamin in healthy volunteers in a randomized, placebo-controlled study. Clin Toxicol 44:17\u201328","journal-title":"Clin Toxicol"},{"key":"1769_CR8","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/ccr3.891","volume":"5","author":"A Koratala","year":"2017","unstructured":"Koratala A, Leghrouz M (2017) Green urine Clin Case Rep 5:549\u2013550","journal-title":"Green urine Clin Case Rep"},{"key":"1769_CR9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s002280000124","volume":"56","author":"C Peter","year":"2000","unstructured":"Peter C et al (2000) Pharmacokinetics and organ distribution of intravenous and oral methylene blue. Eur J Clin Pharmacol 56:247\u2013250","journal-title":"Eur J Clin Pharmacol"},{"key":"1769_CR10","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1182\/blood.V18.5.511.511","volume":"18","author":"G Glass","year":"1961","unstructured":"Glass G et al (1961) Hydroxocobalamin. I. Blood levels and urinary excretion of vitamin B12 in man after a single parenteral dose of aqueous hydroxocobalamin, aqueous cyanocobalamin and cyanocobalamin zinc-tannate complex. Blood 18:511\u2013521","journal-title":"Blood"},{"issue":"4","key":"1769_CR11","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000000408","volume":"3","author":"AJ Sacco","year":"2021","unstructured":"Sacco AJ et al (2021) Hydroxocobalamin in refractory septic shock: a retrospective case series. Crit Care Explor 3(4):e0408","journal-title":"Crit Care Explor"},{"key":"1769_CR12","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1590\/S0102-76382009000400005","volume":"24","author":"PR Evora","year":"2009","unstructured":"Evora PR et al (2009) Methylene blue for vasoplegic syndrome treatment in heart surgery: fifteen years of questions, answers, doubts and certainties. Rev Bras Cir Cardiovasc 24:279\u2013288","journal-title":"Rev Bras Cir Cardiovasc"},{"key":"1769_CR13","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1053\/j.jvca.2019.12.013","volume":"34","author":"J Ortoleva","year":"2020","unstructured":"Ortoleva J et al (2020) Vasoplegia during cardiopulmonary bypass: current literature and rescue therapy options. J Cardiothorac Vasc Anesth 34:2766\u20132775","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"1","key":"1769_CR14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13054-023-04397-7","volume":"27","author":"M Ibarra-Estrada","year":"2023","unstructured":"Ibarra-Estrada M et al (2023) Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial. Crit Care 27(1):110","journal-title":"Crit Care"},{"issue":"5","key":"1769_CR15","doi-asserted-by":"publisher","first-page":"273","DOI":"10.5414\/CN110272","volume":"95","author":"AM Aklilu","year":"2021","unstructured":"Aklilu AM et al (2021) A unique case of purple urine: a case report and literature review. Clin Nephrol 95(5):273\u2013277","journal-title":"Clin Nephrol"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-023-01769-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-023-01769-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-023-01769-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:53:23Z","timestamp":1777564403000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/37\/2\/491\/8306260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,29]]},"references-count":15,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["1769"],"URL":"https:\/\/doi.org\/10.1007\/s40620-023-01769-8","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,29]]},"assertion":[{"value":"23 June 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This research was performed in accordance with the ethical standards of the institutional research committee and with the 1964 declaration and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No animals were utilized for this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Written informed\u00a0consent was obtained from the patient per institutional guidelines.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}